In the latest trading session,, 0.46 million Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) shares changed hands as the company’s beta touched 0.30. With the company’s most
In last trading session, Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) saw 1.39 million shares changing hands with its beta currently measuring 0.28. Company’s recent per share
Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) has a beta value of 0.27 and has seen 1.04 million shares traded in the last trading session. The company,
In the last trading session, 1.44 million shares of the Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) were traded, and its beta was 0.27. Most recently the
In the last trading session, 4.64 million Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) shares changed hands as the company’s beta touched 0.26. With the company’s per
In the last trading session, 1.66 million Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) shares changed hands as the company’s beta touched 0.24. With the company’s per
In last trading session, Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) saw 4.34 million shares changing hands with its beta currently measuring 0.21. Company’s recent per share
In today’s recent session, 0.54 million shares of the Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) have been traded, and its beta is 0.21. Most recently the
In the last trading session, 1.85 million Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) shares changed hands as the company’s beta touched 0.21. With the company’s per
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
